Baluarte, Rowegen .
HRN: 24-30-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/26/2023
AMPICILLIN 1GM (VIAL)
12/26/2023
12/27/2023
IV
2gm
Q6
Prom 18hrs
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes